US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Non/Hallucinogenic Psychedelics

Recent news which mentions Non/Hallucinogenic Psychedelics

Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Tickers ATAI ENVB NEWS
Tags Srinivas Rao Psychedelic Assisted Therapies Psychedelics 2/0
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
Tags News psilocybin therapy Cannabis
From Benzinga